Emv Capital (EMVC)

Sector:

Financials

Index:

FTSE AIM All-Share

47.00p
   
  • Change Today:
      0.50p
  • 52 Week High: 56.50p
  • 52 Week Low: 36.50p
  • Currency: UK Pounds
  • Shares Issued: 27.77m
  • Volume: 35,010
  • Market Cap: £13.05m
  • Beta: 0.05

Latest ShareCast News

Director dealings: Netscientific director ups stake

By Iain Gilbert

Date: Friday 14 Jun 2024

(Sharecast News) - Netscientifc revealed on Friday that executive director Ed Hooper had acquired 20,000 ordinary shares in the AIM-listed life sciences VC group.

NetScientific subsidiary strikes exclusive licensing deal with AstraZeneca

By Josh White

Date: Monday 07 Jun 2021

(Sharecast News) - Life sciences investment company NetScientific announced on Monday that its subsidiary ProAxsis has entered into an exclusive licensing agreement with AstraZeneca.

NetScientific's ProAxsis gets grant for Covid-19 project

By Josh White

Date: Thursday 10 Dec 2020

(Sharecast News) - Technology commercialisation company NetScientific announced on Thursday that its portfolio company ProAxsis has been awarded a high impact Innovate UK grant, as part of the recent 'UKRI Ideas to Address Covid-19' competition.

NetScientific's ProAxsis appoints North American... 19-Nov-2020 ShareCast
NetScientific's PDS investment begins phase 2 tr... 27-Oct-2020 ShareCast
NetScientific acquires rest of ProAxsis for £0.23m 16-Oct-2020 ShareCast
NetScientific joins in PDS Biotechnology public ... 12-Aug-2020 ShareCast
NetScientific agrees to acquire EMV Capital and ... 05-Aug-2020 ShareCast
NetScientific's PDS investment signs deal for Co... 18-Jun-2020 ShareCast
NetScientific CEO stands down to assist with cos... 25-Apr-2019 ShareCast
NetScientific clueless as to surge in share price 14-Mar-2019 ShareCast
No suitors for NetScientific as it suggests deli... 20-Dec-2018 ShareCast
NetScientific's Wanda launches 'CareLink' digita... 15-Aug-2018 ShareCast
NetScientific subsidiary Wanda improve patient a... 18-Jul-2018 ShareCast
Bob Englert to lead NetScientific's Vortex Biosc... 06-Jun-2018 ShareCast
Positive results see NetScientific laud portfoli... 21-May-2018 ShareCast
NetScientific's Wanda signs orthopedics deal wit... 19-Mar-2018 ShareCast
NetScientific portfolio company Axsis bags first... 15-Feb-2018 ShareCast
Netscientific portfolio company nets positive re... 09-Feb-2018 ShareCast
ProAxis expects increased sales of its antibody ... 21-Nov-2017 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Emv Capital Market Data

Currency UK Pounds
Share Price 47.00p
Change Today 0.50p
% Change 1.08 %
52 Week High 56.50p
52 Week Low 36.50p
Volume 35,010
Shares Issued 27.77m
Market Cap £13.05m
Beta 0.05

Emv Capital Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.56% above the market average18.56% above the market average18.56% above the market average18.56% above the market average18.56% above the market average
6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average
Price Trend
52.21% below the market average52.21% below the market average52.21% below the market average52.21% below the market average52.21% below the market average
62.38% below the sector average62.38% below the sector average62.38% below the sector average62.38% below the sector average62.38% below the sector average
Income Not Available
Growth
12.68% above the market average12.68% above the market average12.68% above the market average12.68% above the market average12.68% above the market average
13.98% above the sector average13.98% above the sector average13.98% above the sector average13.98% above the sector average13.98% above the sector average

Emv Capital Dividends

No dividends found

Trades for 14-Oct-2025

Time Volume / Share Price
14:33 5,170 @ 46.25p
11:39 20,000 @ 47.85p
11:50 954 @ 46.25p
10:51 5,000 @ 46.25p
10:46 700 @ 47.20p

Emv Capital Key Personnel

CEO Ilian Iliev

Top of Page